openPR Logo
Press release

Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: A Significant Driver Propelling The Biodefense Market In 2025

05-26-2025 07:23 AM CET | Health & Medicine

Press release from: The Business Research Company

Biodefense

Biodefense

The Biodefense Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Biodefense Market Size and Projected Growth Rate?
The biodefense market has experienced strong growth in recent years. It will grow from $18.55 billion in 2024 to $20.29 billion in 2025, at a compound annual growth rate (CAGR) of 9.4%. This growth is driven by increased government investment in biodefense programs, strengthened regulatory frameworks to expedite product approvals, enhanced collaboration between government, private sector companies, and academic institutions, as well as growing concerns over bioterrorism and geopolitical tensions.

The biodefense market is expected to grow to $28.75 billion by 2029 at a CAGR of 9.1%. Growth drivers include new infectious diseases, biotechnology breakthroughs, and increased global collaboration. Trends include AI use for predictive modeling, next-generation vaccines, and genomic surveillance.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15993

What Are the Major Segments in the Biodefense Market?
The biodefense market covered in this report is segmented -

1) By Type: Anthrax, Smallpox, Botulism, Radiation Or Nuclear, Other Types
2) By Biothreat Detection Device: Samplers, Detectors Or Triggering Devices, Identifiers, Assays, Other Biothreat Detection Devices
3) By Application: Hospitals And Clinics, Ambulatory Care Centers, Other Applications

Subsegments:
1) By Anthrax: Bacillus Anthracis Vaccine, Anthrax Therapeutics
2) By Smallpox: Smallpox Vaccine, Antiviral Drugs For Smallpox
3) By Botulism: Botulism Antitoxin, Botulism Vaccine, Botulinum Neurotoxin Inhibitors
4) By Radiation Or Nuclear: Radiation Protection Drugs, Medical Countermeasures
5) By Other Types: Ricin, Plague, Tularemia, Viral Hemorrhagic Fevers, Other Biotoxins Or Biothreat Agents

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15993&type=smp

What Are The Driving Biodefense Market Evolution?
The recurring threat of emerging infectious diseases is expected to drive the biodefense market. Infectious diseases, caused by pathogens like bacteria and viruses, pose a growing global challenge. Biodefense systems help enhance preparedness and early detection, improving responses to biological threats. The World Health Organization (WHO) reported in November 2023 that tuberculosis (TB) cases reached 10.6 million globally in 2022. As infectious diseases remain a global concern, the biodefense market will continue to grow.

Which Firms Dominate The Biodefense Market Segments?
Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals

What Are the Latest Developing Trends in the Biodefense Market?
Companies in the biodefense market are focusing on developing innovative solutions like nasal COVID-19 vaccines to improve global preparedness against biological threats. Nasal vaccines provide easier administration, potential mucosal immunity, reduce reliance on needles, and improve accessibility. For instance, in January 2023, Bharat Biotech International Limited, a biotechnology company from India, launched the iNCOVACC Nasal COVID-19 vaccine, using a recombinant replication-deficient adenovirus vector. It underwent successful clinical trials and is delivered intranasally via nasal drops, with a two-dose regimen given four weeks apart.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/biodefense-global-market-report

Which Is The Largest Region In The Biodefense Market?
North America was the largest region in the biodefense market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Biodefense Market?
2. What is the CAGR expected in the Biodefense Market?
3. What Are the Key Innovations Transforming the Biodefense Industry?
4. Which Region Is Leading the Biodefense Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: A Significant Driver Propelling The Biodefense Market In 2025 here

News-ID: 4034880 • Views:

More Releases from The Business Research Company

Future of the Creator Economy Insurance Market: Key Innovations and Long-Term Forecasts Through 2034
Future of the Creator Economy Insurance Market: Key Innovations and Long-Term Fo …
What Market Value Will the Creator Economy Insurance Industry Achieve by 2025? Exponential expansion characterizes the recent trajectory of the creator economy insurance sector, which is projected to increase from a value of $1.40 billion in 2024 to $1.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 23.0%. This historical upswing is largely fueled by the expanding cohort of self-employed professionals, the greater consumption of digital content, the
Surging Application Across End Users Powers the Expansion of the Creator Affiliate Management Platform Market in 2025
Surging Application Across End Users Powers the Expansion of the Creator Affilia …
How Much Will the Creator Affiliate Management Platform Market Size Increase by 2025? The sphere of creator affiliate management platforms is experiencing swift expansion, evidenced by its valuation moving from $1.64 billion in the present year, 2024, to an anticipated $1.93 billion throughout 2025, which signifies a compound annual growth rate (CAGR) of 17.4%. This upward trajectory throughout the preceding years is thanks to several key factors: a greater uptake of
Computer Vision For Retail Market Poised for Robust Growth, Projected to Hit $9.87 Billion by 2029
Computer Vision For Retail Market Poised for Robust Growth, Projected to Hit $9. …
Projected Size of the Computer Vision For Retail Market by 2025 The computer vision for retail market has grown rapidly, increasing from $3.41 billion in 2024 to $4.23 billion in 2025, reflecting a CAGR of 24.0%. This growth is driven by the adoption of advanced computer vision technologies, demand for enhanced in-store customer experiences, concerns around retail theft, implementation of intelligent monitoring systems, and increased focus on optimizing inventory management processes. Forecasted
2025-2034 Code Comment Generation Artificial Intelligence (AI) Market Evolution: Emerging Opportunities and Market Disruptions Ahead
2025-2034 Code Comment Generation Artificial Intelligence (AI) Market Evolution: …
Introduction Artificial intelligence is transforming how software development, retail, and cinema operations function by automating complex processes, enhancing efficiency, and improving overall user experiences. Rapid adoption across these sectors has led to significant market growth. The following sections detail the current sizes, future projections, driving factors, trends, segments, and leading companies in three key AI markets: Code Comment Generation, Computer Vision for Retail, and Cinema Operations. Projected Size of the Code Comment

All 5 Releases


More Releases for Biodefense

Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: Transformativ …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Biodefense Industry Market Size Be by 2025? The biodefense sector has experienced robust expansion lately, projected to increase its market valuation from $18.55 billion in 2024 to $20.23 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.1%. This historical upswing is primarily fueled
Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: Strengthening …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Biodefense Market Through 2025? In recent times, there has been significant growth in the biodefense market size. The expansion from $18.55 billion in 2024 to $20.29 billion in 2025, at a compound annual growth rate (CAGR) of 9.4%, can be seen. This
Biodefense Market 2032
The Biodefense Market focuses on developing, integrating, and applying medical interventions such as drugs and vaccinations to protect against bioterrorism. With increasing global awareness of biological threats, advancements in biotechnological research, and the development of effective countermeasures, this market is experiencing significant growth. Download Sample Report Copy Of This Report From Here: https://www.amecoresearch.com/sample/276690 Key Points and Statistics: • Market Size: Projected to reach USD 22,881 Million by 2030, with a CAGR of 5.8%
Biodefense Market - Enhancing Preparedness, Mitigating Threats: Innovative Biode …
Newark, New Castle, USA - new report, titled Biodefense Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biodefense market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biodefense market. The report offers an overview of the market, which briefly describes the
Biodefense Treatment Market 2025| Target U.S For Maximum Profitability in Biodef …
Even though the UN has a convention against biological warfare, the threat of bioterrorism is greater than ever. To counter rogue pathogens and non-state actors, countries must beef up their R&D budgets of biodefense treatments. COVID-19 has raised numerous questions about global safety and security. Fairfield Market Research estimates that the biodefense treatment market should grow at an exponential rate for the forecast period ending in 2025. Get Sample of this
US Biodefense Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title US Biodefense Market Outlook 2022 to its growing collection of premium market research reports. The dangers posed by the weapons of mass destruction have caught the attention of every nation worldwide. These weapons can be characterized by their potential for large-scale destruction and the indiscriminate nature of their effects, notably against civilians. Increasing threat of biological, chemical as well as nuclear